IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended September 30, 2012.
New orders in the quarter totaled $464 million, down 3 percent from the prior year period. Sales in the quarter totaled $480 million, 1 percent higher than the prior year period. For the quarter, on an organic basis, orders were 4 percent lower and sales were 1 percent higher than the prior year period.
Third quarter 2012 operating income, adjusted for $7.1 million of restructuring related charges, was $87.7 million, resulting in an adjusted operating margin of 18.3 percent, equal to the prior year adjusted operating margin.
Excluding the impact of restructuring related charges in both years and the acquisition fair value inventory charge in the prior year, third quarter adjusted earnings per share were 66 cents, a decrease of 5 cents, or 7 percent. The unfavorable year-over-year variance is primarily the result of two one-off items – a prior year benefit from CEO forfeited equity compensation and a true-up of the 2011 year-to-date tax rate.
Free cash flow was $92 million for the quarter, a 7 percent increase from the third quarter of the prior year due to higher operating income and improved working capital.
Additionally, the Company’s Board of Directors has increased the authorized level for repurchases of common stock by $200 million. The increased authorization will be added to the approximately $50 million that remains available from the existing authorization approved by the Board of Directors in December 2011. Repurchases under the program will be funded with future cash flow generation.
Third Quarter Highlights
“We achieved solid profit performance and excellent cash generation in the third quarter in a difficult global environment. Third quarter adjusted EPS of 66 cents exceeded our expectations, primarily as a result of our continued focus on improved productivity and structural cost reductions. Our operating model and team have proven their ability to excel in this environment, which is evident by the 18.3 percent operating margins and record free cash flow generation of $92 million.
Our strong balance sheet and cash generation provide us ample opportunity to deploy capital and remain focused on delivering robust and consistent shareholder returns. In addition to our longstanding investment priorities of organic growth and strategic acquisitions, our Board of Directors has increased the authorization level for the repurchase of our shares by $200 million, providing us with approximately $250 million of total availability. Annually, we intend to repurchase a minimum of one to two percent of the Company’s outstanding shares of common stock, with the flexibility to opportunistically increase the purchases when the stock is trading at a discount to the Company’s intrinsic value. We believe the repurchase of our shares in conjunction with consistent shareholder dividends and strategic acquisitions is a prudent use of our cash flow to maximize our shareholders’ total return.
We expect market conditions to remain challenging, specifically outside the US, resulting in expected fourth quarter flat organic revenue. Despite this market volatility, our disciplined execution allows us to maintain our prior full year 2012 adjusted EPS guidance of $2.65 - $2.70.”
Andrew K. Silvernail
Chairman and Chief Executive Officer
Third Quarter 2012 Business Highlights (Operating margin excludes restructuring related and non-cash fair value inventory charges)
Fluid & Metering Technologies
Health & Science Technologies
Fire & Safety/Diversified Products
For the third quarter of 2012, Fluid & Metering Technologies contributed 41 percent of sales and 42 percent of operating income; Health & Science Technologies accounted for 37 percent of sales and 31 percent of operating income; and Fire & Safety/Diversified Products represented 22 percent of sales and 27 percent of operating income.
Share Repurchase Authorization
The Company’s Board of Directors authorized the repurchase of an additional $200 million of common stock. These repurchases will be made from time to time in either open market transactions or in privately negotiated transactions. Repurchases may also be made under 10b5-1 plans, which would permit shares to be repurchased through pre-determined criteria when the Company would otherwise be prohibited from doing so under insider trading laws. The timing, volume and nature of share repurchases will be at the discretion of management, dependent on market conditions, other priorities of cash investment, applicable securities laws and other factors. This share repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or discontinued at any time.
EBITDA and Free Cash Flow
EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.
|EBITDA and Free Cash Flow Bridge||For the Quarter Ended|
|September 30,||June 30,|
Income before taxes
Depreciation and amortization
CVI fair value inventory charge
Cash Flow from operating activities
Excess tax benefit from stock-based compensation
Free cash flow
Conference Call to be Broadcast over the Internet
IDEX will broadcast its third quarter earnings conference call over the Internet on Tuesday, October 23, 2012 at 9:30 a.m. CT. Chairman and Chief Executive Officer Andy Silvernail and Vice President and Chief Financial Officer Heath Mitts will discuss the Company’s recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 855.859.2056 (or 404.537.3406 for international participants) using the ID # 40918415.
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries – all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to its customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.
For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.
|Condensed Statements of Consolidated Operations|
|(in thousands except per share amounts)|
|Three Months Ended||Nine Months Ended|
|September 30,||September 30,|
|Cost of sales||285,019||295,349||862,578||812,697|
|Selling, general and administrative expenses||107,167||107,296||332,431||313,485|
|Other expense (income) - net||(132||)||441||(19||)||1,001|
|Income before income taxes||70,184||63,101||222,092||206,717|
|Provision for income taxes||20,057||14,765||65,443||60,248|
|Earnings per Common Share:|
|Basic earnings per common share (a)||$||0.60||$||0.58||$||1.88||$||1.77|
|Diluted earnings per common share (a)||$||0.60||$||0.58||$||1.87||$||1.75|
|Basic weighted average common shares outstanding||82,482||82,402||82,820||81,994|
|Diluted weighted average common shares outstanding||83,370||83,586||83,785||83,533|
|Condensed Consolidated Balance Sheets|
|September 30,||December 31,|
|Cash and cash equivalents||$||260,503||$||230,259|
|Receivables - net||277,505||252,845|
|Other current assets||56,292||51,799|
|Total current assets||843,864||789,161|
|Property, plant and equipment - net||223,762||213,717|
|Goodwill and intangible assets||1,869,481||1,813,588|
|Other noncurrent assets||20,328||19,641|
|Liabilities and shareholders' equity|
|Trade accounts payable||$||117,793||$||110,977|
|Total current liabilities||294,042||258,278|
|Other noncurrent liabilities||271,788||258,328|
|Total liabilities and shareholders' equity||$||2,957,435||$||2,836,107|
|Company and Business Group Financial Information|
|(dollars in thousands)|
|Three Months Ended||Nine Months Ended|
|September 30, (b)||September 30, (b)|
|2012||2011 (c)||2012||2011 (c)|
|Fluid & Metering Technologies|
|Net sales||$ 198,000||$ 205,797||$ 621,433||$ 614,367|
|Operating income (d)||42,368||41,462||136,175||124,800|
|Depreciation and amortization||$ 7,246||$ 8,603||$ 22,194||$ 24,841|
|Health & Science Technologies|
|Net sales||$ 176,225||$ 172,911||$ 520,574||$ 442,619|
|Operating income (d) (e)||30,480||32,515||90,494||91,881|
|Depreciation and amortization||$ 10,273||$ 9,712||$ 29,293||$ 20,686|
|Fire & Safety/Diversified Products (c)|
|Net sales||$ 108,199||$ 98,735||$ 328,173||$ 302,814|
|Operating income (d)||26,807||20,965||78,165||68,972|
|Depreciation and amortization||$ 1,622||$ 1,844||$ 5,225||$ 6,561|
|Net sales||$ 479,859||$ 476,881||$ 1,463,420||$ 1,357,768|
|Operating income (d)||87,673||87,036||268,411||247,386|
|Depreciation and amortization (f)||$ 19,545||$ 20,540||$ 57,938||$ 53,116|
|(a)||Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share.|
|(b)||Three and nine month data includes acquisitions of Matcon (July 2012), ERC (April 2012), CVI Melles Griot (June 2011), Microfluidics (March 2011) and Advanced Thin Films (January 2011) in the Health & Science Technologies segment from the date of acquisition.|
|(c)||Financial data for 2011 has been revised to reflect the transfer of our Trebor business unit from the Health & Science Technologies segment to the Fluid & Metering Technologies segment as well as the movement of the Dispensing Equipment segment into the Fire & Safety/Diversified Products segment.|
|(d)||Group operating income excludes unallocated corporate operating expenses while both Group and Company operating income excludes restructuring related charges.|
|(e)||Operating income excludes $12.8 million and $15.8 million for the three and nine months ending September 30, 2011, respectively, related to a non-cash acquisition fair value inventory charge.|
|(f)||Depreciation and amortization excludes amortization of debt issuance expenses.|